Literature DB >> 8424508

A randomized double-blind comparison of epidural fentanyl infusion versus patient-controlled analgesia with morphine for postthoracotomy pain.

H T Benzon1, H Y Wong, A M Belavic, I Goodman, D Mitchell, T Lefheit, J Locicero.   

Abstract

The authors conducted a prospective, randomized, double-blind comparison of an epidural fentanyl infusion versus patient-controlled analgesia (PCA) with morphine in the management of postthoracotomy pain. Thirty-six patients were randomized into one of two groups. The epidural group received an epidural fentanyl infusion, 10 micrograms/mL, and saline through their PCA machine. The PCA group received an epidural saline infusion and morphine, 1.0 mg/mL, through their PCA device. The infusions were escalated according to a study protocol when pain relief was deemed inadequate by the patients. Pain relief was evaluated by a visual analog pain scale (VAS), both at rest and during coughing, and by verbal rating scores (VRS) of pain relief. Degree of sedation and the frequency of nausea, vomiting, and pruritus were also noted. The VAS, VRS, degree of sedation, and side effects were evaluated every 2 h from 7 AM to 7 PM, for 72 h after surgery. Forced vital capacities were determined before surgery and at 24, 48, and 72 h after surgery. The VAS were significantly lower (P = 0.001), and the Total Pain Relief scores higher (P < 0.02) in the epidural group, signifying better analgesia. There were no differences in postoperative forced vital capacity between the two groups. More patients in the PCA group had greater degrees of sedation on postoperative day 1 (P = 0.005), whereas pruritus was more frequent (P < 0.02) in the epidural group. We conclude that an epidural fentanyl infusion is superior to that of PCA with morphine in the management of pain after thoracotomy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424508

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  Epidural opioids for post-thoracotomy pain.

Authors:  R P Grant
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

2.  [The clinical use of spinal opioids, part 1].

Authors:  N Rawal
Journal:  Schmerz       Date:  1996-08-26       Impact factor: 1.107

3.  Comparative Study of Epidural Dexmedetomidine, Fentanyl, and Tramadol as Adjuvant to Levobupivacaine for Lower Limb Orthopedic Surgeries.

Authors:  Usha Shukla; Dheer Singh; Jheelam Singh; Jay Brijesh Singh Yadav
Journal:  Cureus       Date:  2022-05-22

Review 4.  The benefits of adding epidural analgesia to general anesthesia: a metaanalysis.

Authors:  Joanne Guay
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

5.  Epidural analgesia versus patient-controlled intravenous analgesia for pain following intra-abdominal surgery in adults.

Authors:  Jon H Salicath; Emily Cy Yeoh; Michael H Bennett
Journal:  Cochrane Database Syst Rev       Date:  2018-08-30

6.  Comparative evaluation of epidural bupivacaine - dexmedetomidine and bupivacaine -fentanyl on Doppler velocimetry of uterine and umbilical arteries during labor.

Authors:  Mohamed Fouad Selim; Ali Mohamed Ali Elnabtity; Ali Mohamed Ali Hasan
Journal:  J Prenat Med       Date:  2012-07

7.  Comparative evaluation of dexmedetomidine and fentanyl for epidural analgesia in lower limb orthopedic surgeries.

Authors:  Sukhminder Jit Singh Bajwa; Vikramjit Arora; Jasbir Kaur; Amarjit Singh; S S Parmar
Journal:  Saudi J Anaesth       Date:  2011-10

8.  Comparative analysis of epidural bupivacaine versus bupivacaine with dexmedetomidine for vaginal hysterectomy.

Authors:  Seema Shreepad Karhade; Shilpa Amol Acharya; Kalpana Harnagale
Journal:  Anesth Essays Res       Date:  2015 Sep-Dec

9.  Dexmedetomidine versus fentanyl added to bupivacaine for epidural analgesia in combination with general anesthesia for elective lumbar disc operations: A prospective, randomized double-blinded study.

Authors:  Amin Mohammed Alansary; Marwa Ahmed Khairy Elbeialy
Journal:  Saudi J Anaesth       Date:  2019 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.